Although there are many medicines available for the treatment of AD in the clinic, such as the acetylcholinesterase inhibitor, rivastigmine, and the low-affinity NMDA (N-methyl-d-aspartate) receptor antagonist, memantine, neither one of these can really treat the underlying causes of AD except for just rendering some modest symptomatic improvement. This evidence concerns the gene ACHE and Alzheimer disease.